Abstract: A candesartan cilexetil-containing preparation contains candesartan cilexetil and lauromacrogol. The lauromacrogol may be contained at a ratio of 2.4 parts by weight or less with respect to 100 parts by weight of the candesartan cilexetil-containing preparation. The candesartan cilexetil-containing preparation may further contain at least one kind of pharmacologically acceptable additives among a diluent, a disintegrant and a binder.

Abstract: A production method of pharmaceutical composition contains candesartan cilexetil, comprising dissolving a water-soluble polymer and a sugar alcohol to purified water and dispersing candesartan cilexetil to prepare a dispersion liquid of candesartan cilexetil, granulating by a wet process using the dispersion liquid together with a powdery additive to obtain a granulated product, drying the granulated product, particle size regulating the granulated product; and tableting the granulated product, wherein the dispersion liquid contains the amount of water-soluble polymer within a range of 0.05 parts by weight or more and 0.5 parts by weight or less, based on 100 parts by weight of the pharmaceutical composition, and the dispersion liquid contains the amount of sugar alcohol within a range of 5 parts by weight or more and 20 parts by weight or less, based on 100 parts by weight of the pharmaceutical composition.

Abstract: The present invention provides a pharmaceutical composition containing candesartan cilexetil, which is produced by wet granulation using a dispersion liquid of candesartan cilexetil together with a powdery additive. The dispersion liquid may also contain a water-soluble polymer, a sugar alcohol, or a stabilizer, and the water-soluble polymer may be hydroxypropylcellulose. The sugar alcohol may be mannitol. In addition, the stabilizer may be lauromacrogol.

Abstract: A candesartan cilexetil-containing preparation contains candesartan cilexetil and lauromacrogol. The lauromacrogol may be contained at a ratio of 2.4 parts by weight or less with respect to 100 parts by weight of the candesartan cilexetil-containing preparation. The candesartan cilexetil-containing preparation may further contain at least one kind of pharmacologically acceptable additives among a diluent, a disintegrant and a binder.

Abstract: A semiconductor integrated circuit having a decoder for decoding a first signal supplied thereto and having a plurality of bits and outputting a second signal in which only a predetermined bit of the plurality of bits of the first signal is set at active level, and an internal circuit for, in an ordinary operation mode in which a standby signal is at first level, performing a predetermined processing operation in response to the second signal decoded by said decoder and, in a standby mode in which the standby signal is at second level, stopping the predetermined processing operation to be set in a low power consumption state, comprising a signal level fixing circuit for, when the standby signal is at second level, fixing the predetermined bit of the plurality of bits of the first signal at predetermined level, and supplying a resultant signal to said decoder.